Navigation Links
InfaCare Pharmaceutical Corporation Raises $28 Million in Series B Financing to Advance Its Neonatal Pipeline
Date:10/27/2008

TREVOSE, Pa., Oct. 27 /PRNewswire/ -- InfaCare Pharmaceutical Corporation, a late stage specialty pharmaceutical company focused on the development of products to treat neonatal diseases, today announced a $28 million private placement of its Series B Preferred Stock. New investor, HealthCare Ventures, led the round and Harold Werner, a partner with HCVEN, will join InfaCare's board of directors. Additional funding came from new investor Longitude Capital. Patrick Enright, a partner with Longitude and a current InfaCare board member, will represent the fund. All current preferred stock investors, including FirstMark Capital and Atlas Venture, also participated in the financing.

"We are very excited to have such strong financial backing from this outstanding group of both new and existing investors, whose participation in this round further validates our business strategy and the value of our lead drug candidate," said Dan Burns, President and Chief Executive Officer. "We expect the proceeds of this financing to provide the capital necessary to achieve value creating milestones for the company, including phase IIb results for our lead product."

InfaCare's lead compound, Stanate(R) for the treatment of neonatal hyperbilirubinemia, is expected to enter a pivotal phase III trial in 2009. Stanate is the only pharmacological agent, currently in development, designed to prevent bilirubin from reaching toxic levels in hemolyzing neonates, thus reducing or eliminating the risk of the devastating neurological outcomes associated with uncontrolled hyperbilirubinemia. Over 1,200 neonates have been treated with Stanate in a number of clinical trials to date.

About InfaCare Pharmaceutical Corporation

InfaCare Pharmaceutical Corp. is a Pennsylvania based specialty pharmaceutical company dedicated to developing and commercializing therapeutics to treat neonatal diseases. Stanate, InfaCare's lead product is a Heme Oxygenase Inhibitor designed to re
'/>"/>

SOURCE InfaCare Pharmaceutical Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... MLF Biotech, Inc. has developed a ... Probiotics for Pets helps maintain digestive health and can ... intestinal flora after it experiences a period of stress, ... for Pets is a proprietary blend of pure probiotics ... active bacteria strains that are safe and effective for ...
(Date:11/21/2014)... City, Mo (PRWEB) November 21, 2014 ... received the Get With The Guidelines®–Heart Failure Gold-Plus ... measures outlined by the American Heart Association/American College ... for heart failure patients. , Get With The ... helps hospital teams provide the most up-to-date, research-based ...
(Date:11/21/2014)... Big Bud Farms announced today that ... Innovations with Ed Begley Jr., airing via Discovery Channel ... Big Bud Farms, growers of legal medical marijuana, provide ... of medical marijuana. , This segment of Innovations takes ... of products for medicating. Viewers will learn about the ...
(Date:11/21/2014)... 21, 2014 Recently, VogueQueen ... a wedding dress promotion for the coming holiday season. ... special offer when checking out. , The beach wedding ... The customers like the designs for the premium quality ... not only be good for the environment, they would ...
(Date:11/21/2014)... Midway through the research period for the ... Directory of Health Plans, preliminary data shows volatility in ... Plans is a comprehensive resource with enrollment data and ... The 2015 edition will be available in ... Databases Division, the company’s exclusive in-house research team, have ...
Breaking Medicine News(10 mins):Health News:MLF Biotech Introduces Liv-Pro Probiotics for Pets 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4Health News:Big Bud Farms to be Featured in Upcoming Episode of Innovations with Ed Begley Jr. 2Health News:Beach Wedding Dresses on Sale for the Coming Holiday Season at VogueQueen.com 2Health News:Data from Atlantic Information Services’s Forthcoming Directory Shows Volatility in U.S. Health Care Market 2
... ... ... ... ...
... ... injury lawyer, David Perecman, questions whether anyone should continue driving them before having them fixed. ... New York (PRWEB) March 4, 2010 -- ... the New York Post , Jerry Silver, 86, lost control of his car and collided ...
... admission, , THURSDAY, March 4 (HealthDay News) -- Hospices ... to turn off their implanted defibrillators, causing unnecessary discomfort, ... more than 400 hospices that responded to a survey ... form that would identify people with defibrillators, and just ...
... ... ... , ... , , ...
... that can replicate the human brain, or to develop ... interfacing with neurons and other types of cellular networks? ... advancing each other in ways that could propel extraordinary ... topic of an hour-long conversation recently led by neuroscientist ...
... ... ... ... ...
Cached Medicine News:Health News:National Healthcare Leaders in San Francisco to Address Health Reform and Payment Reform 2Health News:National Healthcare Leaders in San Francisco to Address Health Reform and Payment Reform 3Health News:National Healthcare Leaders in San Francisco to Address Health Reform and Payment Reform 4Health News:New York Personal Injury Lawyers Concerned About Toyota Accident in Queens 2Health News:New York Personal Injury Lawyers Concerned About Toyota Accident in Queens 3Health News:Hearts of Hospice Patients Being Needlessly Shocked 2Health News:Hearts of Hospice Patients Being Needlessly Shocked 3Health News:Healthcare Trust of America, Inc. Acquires an 80,562 Square Foot Medical Office Portfolio Located in Atlanta, Georgia for $19,550,000 2Health News:Healthcare Trust of America, Inc. Acquires an 80,562 Square Foot Medical Office Portfolio Located in Atlanta, Georgia for $19,550,000 3Health News:Healthcare Trust of America, Inc. Acquires an 80,562 Square Foot Medical Office Portfolio Located in Atlanta, Georgia for $19,550,000 4Health News:Healthcare Trust of America, Inc. Acquires an 80,562 Square Foot Medical Office Portfolio Located in Atlanta, Georgia for $19,550,000 5Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 2Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 3Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 4Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 5Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 6Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 7Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 8Health News:Contact Dermatitis Can Be Irritating, Especially When the Cause is a Mystery 9
(Date:11/21/2014)... CORONA, Calif. and VIENNA, Va. ... an innovative in-home care provider that operates in ... with BeClose, a leading provider of remote caregiving technology. Alta ... new and existing client receiving homecare services. ... believe this technology is the key to providing the ...
(Date:11/21/2014)...  Heated dialogue in recent months about the rising ... to Gilead,s new hepatitis C drug Harvoni® – has ... what it means to put a price on patient ... while drug pricing is one of the most debated ... general business and ethical standpoint – it is also ...
(Date:11/21/2014)... MELVILLE, N.Y. , Nov. 21, 2014 /PRNewswire/ ... of the world,s largest health care services companies, and ... world,s largest provider of health care products and services ... announced that the companies have entered into a long-term ... service and product offerings to office-based medical practices.  This ...
Breaking Medicine Technology:Alta Home Care, Inc. and BeClose Partner to Enable Seniors to Remain in Their Homes Safely and Securely 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 2"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 3"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 4"The Price of Global Health" Tackles Worldwide Drug-Pricing Debate 5Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 2Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 3Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 4Cardinal Health And Henry Schein Enter Into Long-Term Strategic Agreement To Serve Physician Offices 5
... SAN DIEGO, and PARSIPPANY, N.J., Feb. 15, 2011 ... ), an emerging specialty pharmaceutical company, today announced ... its Phase 3 trial of EXPAREL™ (bupivacaine extended-release ... safety in wound healing and significantly improved efficacy ...
... 15, 2011 MIM Software Inc., a leading global ... MIM™ is available on the U.S. App Store. This ... the app had received 510(k) clearance for remote diagnostic ... the iPhone®, iPod touch®, and iPad®. (Photo: ...
Cached Medicine Technology:Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting 2Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting 3Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting 4Pacira Pharmaceuticals Highlights Additional Safety Data on EXPAREL™ for Postsurgical Pain Relief at 2011 American Academy of Orthopaedic Surgeons Annual Meeting 5Mobile MIM, First FDA-Cleared Diagnostic Medical Imaging App, Now Available on the U.S. App Store 2Mobile MIM, First FDA-Cleared Diagnostic Medical Imaging App, Now Available on the U.S. App Store 3
... The MagMAX™ AI/ND Viral RNA Isolation ... purification of Avian Influenza (AI) and / ... pharynx / tracheal and cloacal swab samples. ... Veterinary Services Laboratories for use in their ...
... The ViralXpress™ kit provides a rapid ... of amplification-competent nucleic acids; however, the ... RNA. Purification of either RNA or ... the purified material with either DNase ...
... This revolutionary product will provide you ... type of electroretinogram, visual evoked potential, ... ganzfeld will allow you to perform ... on-off, double flash, photopic negative response, ...
The Mago® Plus Automated EIA Analyzer is a fully automated, integrated ELISA system. Together, with immunosimplicity® reagents, the Mago® Plus provides a flexible, integrated solution ...
Medicine Products: